Statistics for A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian CancerA Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
Total visits
| views | |
|---|---|
| A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian CancerA Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer | 82 |
Total visits per month
| views | |
|---|---|
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
File Visits
| views | |
|---|---|
| nihms-1546537.pdf | 125 |
Top country views
| views | |
|---|---|
| United States | 61 |
| Canada | 3 |
| China | 1 |
| Germany | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 39 |
| Fairfield | 5 |
| Houston | 3 |
| Toronto | 3 |
| Ann Arbor | 2 |
| Cambridge | 2 |
| Baltimore | 1 |
| Duncan | 1 |
| Frankfurt Am Main | 1 |
| Mountain View | 1 |
| Seremban | 1 |
| Stockholm | 1 |